LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.56234
 34.30 27.76 1445 2449 0.5899 0.8432
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 36.01 27.76 255 2662 0.0958 0.4005
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 36.01 27.76 1411 2662 0.5299 0.8161
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 36.01 27.76 100 2662 0.0376 0.2149
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 36.01 27.76 1500 2662 0.5633 0.8330
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 37.71 27.76 304 2877 0.1056 0.4297
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 37.71 27.76 1474 2877 0.5122 0.8098
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 37.71 27.76 125 2877 0.0434 0.2520
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 37.71 27.76 1550 2877 0.5386 0.8235
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 39.41 27.76 314 3105 0.1011 0.4282
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 39.41 27.76 1530 3105 0.4927 0.8024
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 39.41 27.76 119 3105 0.0383 0.2385
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 39.41 27.76 1611 3105 0.5187 0.8161
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 41.11 27.76 317 3331 0.0952 0.4227
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 41.11 27.76 1562 3331 0.4689 0.7923
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 41.11 27.76 141 3331 0.0423 0.2653
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 41.11 27.76 1684 3331 0.5055 0.8119
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 42.81 27.76 328 3596 0.0912 0.4218
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 42.81 27.76 1637 3596 0.4552 0.7878
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 42.81 27.76 168 3596 0.0467 0.2925
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 42.81 27.76 1768 3596 0.4916 0.8075
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 44.52 27.76 376 3884 0.0968 0.4414
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 44.52 27.76 1704 3884 0.4387 0.7817
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 44.52 27.76 146 3884 0.0376 0.2622
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 44.52 27.76 1786 3884 0.4598 0.7935
MN20160318_Q01
L15